Publicacións nas que colabora con Juan Jesús Gómez-Reino Carnota (47)

2019

  1. Visfatin as a therapeutic target for rheumatoid arthritis

    Expert Opinion on Therapeutic Targets, Vol. 23, Núm. 7, pp. 607-618

2017

  1. Adipokines induce pro-inflammatory factors in activated Cd4+ T cells from osteoarthritis patient

    Journal of Orthopaedic Research, Vol. 35, Núm. 6, pp. 1299-1303

  2. Leptin in the interplay of inflammation, metabolism and immune system disorders

    Nature Reviews Rheumatology, Vol. 13, Núm. 2, pp. 100-109

2014

  1. Adipokines as drug targets in joint and bone disease

    Drug Discovery Today, Vol. 19, Núm. 3, pp. 241-258

  2. Adipokines, metabolic syndrome and rheumatic diseases

    Journal of Immunology Research, Vol. 2014

  3. Adiponectin and leptin: New targets in inflammation

    Basic and Clinical Pharmacology and Toxicology, Vol. 114, Núm. 1, pp. 97-102

  4. An update on leptin as immunomodulator

    Expert Review of Clinical Immunology, Vol. 10, Núm. 9, pp. 1165-1170

  5. Bone metabolism and adipokines: Are there perspectives for bone diseases drug discovery?

    Expert Opinion on Drug Discovery, Vol. 9, Núm. 8, pp. 945-957

  6. Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals

    Annals of the Rheumatic Diseases

  7. Endogenous cannabinoid anandamide impairs cell growth and induces apoptosis in chondrocytes

    Journal of Orthopaedic Research, Vol. 32, Núm. 9, pp. 1137-1146

  8. NUCB2/nesfatin-1: A new adipokine expressed in human and murine chondrocytes with pro-inflammatory properties, an in vitro study

    Journal of Orthopaedic Research, Vol. 32, Núm. 5, pp. 653-660

2013

  1. Adipokines, molecular players at the crossroad between inflammation and oxidative stress: Role in arthropathies

    Studies on Arthritis and Joint Disorders (Springer New York), pp. 67-88

  2. Adipokines: Novel players in rheumatic diseases

    Discovery Medicine, Vol. 15, Núm. 81, pp. 73-83